Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Prothena Corp Public (PRTA) EBITDA: 2011-2024

Historic EBITDA for Prothena Corp Public (PRTA) over the last 14 years, with Dec 2024 value amounting to -$154.6 million.

  • Prothena Corp Public's EBITDA rose 39.50% to -$40.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$255.3 million, marking a year-over-year decrease of 51.82%. This contributed to the annual value of -$154.6 million for FY2024, which is 19.09% up from last year.
  • Per Prothena Corp Public's latest filing, its EBITDA stood at -$154.6 million for FY2024, which was up 19.09% from -$191.0 million recorded in FY2023.
  • Prothena Corp Public's EBITDA's 5-year high stood at $72.0 million during FY2021, with a 5-year trough of -$191.0 million in FY2023.
  • In the last 3 years, Prothena Corp Public's EBITDA had a median value of -$154.6 million in 2024 and averaged -$159.1 million.
  • Its EBITDA has fluctuated over the past 5 years, first skyrocketed by 163.84% in 2021, then plummeted by 282.78% in 2022.
  • Over the past 5 years, Prothena Corp Public's EBITDA (Yearly) stood at -$112.7 million in 2020, then skyrocketed by 163.84% to $72.0 million in 2021, then slumped by 282.78% to -$131.6 million in 2022, then tumbled by 45.21% to -$191.0 million in 2023, then grew by 19.09% to -$154.6 million in 2024.